Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - European Market Recap: FTSE 100 (0.07%) to 10878.12, DAX +0.08% to 26285.96, CAC40 +0.27% to 8462.39, STOXX 600 (0.01%) to 656.41

Aug 26 ,2026

  • Synopsis:

    • European equity markets closed mixed after reversing afternoon gains. Banks, Personal&Household Goods and Chemicals were the top gaining sectors whilst Health Care, Media and Technology lagged. Follows mostly firmer performance on Tuesday. Stoxx 600 up 0.6% on the week and on track for fifth positive month in a row.

    • Focus on pullback in oil amid reports about progress on reopening Strait of Hormuz. Iran and Oman finalizing previously announced agreement to establish an alternative and temporary shipping lane. Axios sources said Rubio told counterparts White House has settled on strategy of continuing economic pressure in favor of restarting military action. US officials believe Iran has lost control of Hormuz oil flows. Comes amid reports of significant progress in Iran-Pakistan mediation talks, though US denied it is negotiating.

    • Sentiment on European markets remains upbeat. Few contrarian voices suggest tailwinds well understood, with lack of fresh catalysts. In macro news, ECB sources tipped a September rate hike via Reuters, while Executive Board member Schnabel said economy appears to be gaining momentum. IFO said German export-sector confidence highest since Feb-2022. Citi/YouGov showed a rise in UK inflation expectations in August after recent falls, which reflects elevated oil/gas prices and cost of living pressures. Survey showed one in three UK employers cut entry levels jobs. Switzerland August ZEW economic sentiment improved to 12.1 versus 10.0 prior.

    • In corporate news, out of DACHs, Stadler Rail (SRAIL.SW) out with H1 earnings and confirmed outlook. SoftwareONE (SWON.SW) posted strong H1 report. Gurit (GURN.SW) out with H1 earnings and raised sales and profit guidance. Overnight, Siemens Energy (ENR.GR) announced the initiation of work to separate Transformation of Industry segment into standalone company. In the Nordics, Ambu (AMBU.B.DC) posted Q3 numbers and updated FY25/26 outlook to reflect slower volume uptake in Anesthesia & Patient Monitoring. BioArctic (BIOA.B.SS) out with Q2 numbers. Gubra (GUBRA.DC) achieved milestone from AbbVie (ABBV) following initiation of a Phase 2 clinical trial of ABBV-295. In the UK, Hochschild Mining (HOC.LN) higher post H1.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Banks +0.76%, Persnl & HHold Goods +0.73%, Chemicals +0.57%, Construct & Mtls +0.56%, Travel & Leisure +0.44%, Ind Goods & Svcs +0.43%, Food & Beverage +0.32%, Basic Resources +0.29%, Insurance +0.24%, Retail +0.09%, Financial Svcs +0.08%

      • Underperformers:

        • Health Care (1.00%), Media (0.86%), Technology (0.84%), Telecom (0.81%), Oil & Gas (0.80%), Autos & Parts (0.61%), Real Estate (0.51%), Utilities (0.14%),

    • Macro:

      • ECB

        • Policymakers ready to raise rates to 2.50% in Sep to curb Iran war-driven inflation, but reluctant to signal further tightening - Reuters

        • Isabel Schnabel calls for further rate hikes as Middle East conflict and strong euro-zone economy fuel inflation risks - Bloomberg

      • France:

        • Faces perilous budget showdown amid high debt, gridlocked parliament, and rising bond yields ahead of 2027 election - Bloomberg

        • Mélenchon proposes ECB waive interest on French debt; rivals denounce plan as dangerous ahead of 2027 presidential race - Politico

      • Germany:

        • AfD leads polls in Saxony-Anhalt regional election, raising prospect of far-right minister-president amid economic concerns - EurActiv

        • Export expectations in Germany rise sharply in Aug according to latest Ifo survey - release

      • Greece:

        • Finance Minister defends strategy to accelerate early repayment of Greece's public debt - ekathimerini

      • Sweden

        • Sweden's ruling coalition trails in poll, but closes gap on centre-left opposition - Reuters

      • UK:

        • Andy Burnham pledges to 'take pressure off' business ahead of October Budget - FT

        • Labour MPs will push Burnham to back voting reform in first 100 days - Guardian

        • UK energy secretary says looking at 'what more we can do' as typical annual bill rises to £1,723 from October - Guardian

        • UK PM Andy Burnham urges firms to offer work experience placements to tackle youth unemployment crisis; Sainsbury's pledges 10,000 spots - Bloomberg

        • Burnham looks at giving mayors in England power to block sale of council homes - FT

        • One in three UK employers cut the number of entry-level jobs - Lancaster University's Work Foundation

    • Company news:

      • Notable Gainers

        • +22.4% SRAIL.SW (Stadler Rail CHF30.02, +5.50) -- H1 earnings

        • +22.3% ATORX.SS (Alligator Bioscience SEK0.03, +0.01) -- Q2 earnings

        • +20.8% GURN.SW (Gurit Holding CHF35.40, +6.10) -- H1 earnings; raises FY guidance

        • +11.6% ADXN.SW (Addex Therapeutics CHF0.03, -0.00) -- sells 437,869 ADSs through it's At the Market offering agreement with H.C. Wainwright & Co

        • +11.1% NXQ.LN (Nexteq £0.50, +0.05) -- order

        • +9.7% CRNA.NO (Circio Holding NOK13.08, +1.16) -- Company and Full Circles Therapeutics jointly announce in vivo cell therapy research

        • +9.5% SWON.SW (SoftwareONE Holding CHF9.47, +0.83) -- H1 earnings

        • +8.5% CAML.LN (Central Asia Metals £1.82, +0.14) -- H1 earnings

        • +6.7% AGFB.BB (Agfa-Gevaert €0.46, +0.03) -- Q2 earnings

        • +6.3% SALM.NO (Salmar NOK578.00, +34.00) -- re-instated buy at Arctic Securities; Nordea upgrade

        • +5.4% HOC.LN (Hochschild Mining £6.59, +0.34) -- H1 earnings

        • +4.3% DBK.GR (Deutsche Bank €34.63, +1.43)

        • +4.1% KENDR.NA (Kendrion €19.70, +0.78) -- Q2 earnings

        • +4.1% TESB.BB (Tessenderlo Group €21.65, +0.85) -- Kepler Cheuvreux upgrade

        • +3.9% CLAS.B.SS (Clas Ohlson SEK452.00, +16.80)

        • +3.8% VVV3.GR (Ökoworld €27.20, +1.00) -- H1 earnings

        • +3.2% MT.NA (ArcelorMittal €64.56, +2.00)

        • +3.2% WAC.GR (Wacker Neuson €22.60, +0.70)

        • +3.0% KCR.FH (Konecranes €30.32, +0.88) -- SEB upgrade

        • +2.9% CSN.LN (Chesnara £3.50, +0.10)

        • +2.4% BSL.GR (Basler €23.45, +0.55)

        • +1.9% ACKB.BB (Ackermans & Van Haaren €262.40, +4.80) -- notes portfolio company DEME releases H1 earnings

        • +1.8% GOMX.SS (GomSpace Group SEK11.35, +0.20) -- Q2 earnings

      • Notable Decliners

        • -15.8% AMBU.B.DC (Ambu DKK66.05, -12.35) -- updates financial outlook for 2025/26; Q3 earnings

        • -13.9% 2020.NO (2020 Bulkers NOK4.35, -0.70) -- Q2 earnings

        • -6.7% BIOA.B.SS (BioArctic SEK322.00, -23.00) -- Q2 earnings

        • -6.2% PAAL.B.DC (Per Aarsleff Holding DKK728.00, -48.00) -- Q3 earnings

        • -5.2% IBT.B.SS (Infant Bacterial Therapeutics SEK65.00, -3.60) -- Q2 earnings

        • -4.7% ACTI.SS (Active Biotech SEK5.24, -0.26)

        • -4.3% PREC.SS (Precise Biometrics SEK0.68, -0.03) -- Q2 earnings

        • -4.2% CAM.LN (Camellia £56.50, -2.50) -- H1 earnings

        • -3.8% SGE.LN (Sage Group £10.63, -0.41)

        • -3.6% HLAG.GR (Hapag-Lloyd €133.00, -4.90)

        • -3.3% WAWI.NO (Wallenius Wilhelmsen NOK157.50, -5.32)

        • -3.0% HM.B.SS (H&M Hennes & Mauritz SEK179.00, -5.50) -- Handelsbanken downgrade

        • -2.9% SAP.GR (SAP €180.02, -5.44) -- UBS downgrade

        • -2.7% TECN.SW (Tecan Group CHF188.10, -5.20) -- Oddo downgrade

        • -2.6% MGN.NO (Magnora NOK22.65, -0.60) -- Q2 earnings

        • -1.9% ALZCUR.SS (AlzeCure Pharma SEK6.28, -0.12) -- Q2 earnings

        • -1.8% SCT.LN (Softcat £20.44, -0.38) -- Deutsche Numis downgrade

    • EU companies reporting tomorrow:

      • Earnings:

        • Austria: EVN (EVN.AV), PORR (POS.AV)

        • Belgium: Ageas (AGS.BB), CMB.TECH (CMBT.BB), Tessenderlo Group (TESB.BB), Ion Beam Applications (IBAB.BB), Cie d'Entreprises CFE (CFEB.BB)

        • Denmark: Danske Andelskassers Bank (DAB.DC), MT Hojgaard Holding (MTHH.DC), NNIT (NNIT.DC), Møns Bank (MNBA.DC), RTX (RTX.DC), Luxor (LUXOR.B.DC), Ostasiatiske Kompagni (OKEAC.DC)

        • Finland: Keskisuomalainen (KSL.FH)

        • France: Pernod Ricard (RI.FP), TotalEnergies EP Gabon (EC.FP)

        • Germany: Delivery Hero (DHER.GR), Fielmann Group (FIE.GR), ASTA Energy Solutions (1AST.GR), Hygieia Biomedical (50I.GR), IVU Traffic Technologies (IVU.GR), Ringmetall (HP3A.GR), BRAIN Biotech (BNN.GR), Bertelsmann (002JGK-E)

        • Netherlands: HAL Trust (HAL.NA), Eurocommercial Properties (ECMPA.NA), Azerion Group (AZRN.NA)

        • Norway: Måsøval (MAS.NO), Andfjord Salmon Group (ANDF.NO), Grieg Seafood (GSF.NO), Agilyx (AGLX.NO), Integrated Wind Solutions (IWS.NO), Norcod (NCOD.NO), Omda (OMDA.NO), Oncoinvent (ONCIN.NO), Electromagnetic Geoservices (VOIM.NO)

        • Southern Europe: Allwyn (ALWN.GA), Mota-Engil SGPS (EGL.PL), Aquafil (ECNL.IM)

        • Sweden: L E Lundbergföretagen (LUND.B.SS), Elekta (EKTA.B.SS), Systemair (SYSR.SS), Sivers Semiconductors (SIVE.SS), Nordrest Holding (NREST.SS), BioInvent International (BINV.SS), Eolus Aktiebolag (EOLU.B.SS), Oncopeptides (ONCO.SS), Arctic Falls (ARFA.SS), Saniona (SANION.SS), Elon (ELON.SS)

        • Switzerland: Accelleron Industries (ACLN.SW), Feintool International Holding (FTON.SW), Bajaj Mobility (BMAG.SW)

        • UK: PPHE Hotel Group (PPH.LN), Partners Group Private Equity (PEY.LN), Macfarlane Group (MACF.LN), Jadestone Energy (JSE.LN)

      • Traffic: VINCI (DG.FP)

      • CMD/Events: Blue Cap (B7E.GR),Frequentis (FQT.GR)

  • Data:

    • Economics:

      • Sweden Jul PPI +6.4% y/y vs consensus +6.9% and prior +7.4%

      • Switzerland Aug ZEW Expectations 12.1 vs consensus 8.0 and prior 10.0

    • Markets:

      • WTI Crude (Oct 26): +$0.00 or +0.00% to $82.36

      • €-$ (0.0022) or (0.19%) to 1.1653

      • £-$ (0.0052) or (0.38%) to 1.3595

      • €-£ +0.0019 to 0.8574

      • S&P 500 (0.07%)

      • Performance year-to-date

        • FTSE 100: +9.53%

        • DAX: +7.33%

        • CAC: +3.84%

        • MIB: +17.66%

        • Stoxx 600: +10.84%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.